EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 20 filers reported holding EYEGATE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $10,000 | -41.2% | 42,365 | -24.2% | 0.00% | – |
| Q3 2018 | $17,000 | +240.0% | 55,855 | +343.2% | 0.00% | – |
| Q1 2018 | $5,000 | -84.8% | 12,603 | -58.7% | 0.00% | -100.0% |
| Q4 2017 | $33,000 | -10.8% | 30,483 | -4.8% | 0.00% | -66.7% |
| Q3 2017 | $37,000 | +42.3% | 32,022 | +216.0% | 0.00% | -40.0% |
| Q1 2017 | $26,000 | – | 10,135 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |